Literature DB >> 22677303

Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin.

Srecko Marusic1, Nives Gojo-Tomic, Vesna Bacic-Vrca, Miljenko Franic.   

Abstract

OBJECTIVE: To present the case of warfarin-cloxacillin interaction that resulted in an increased international normalized ratio (INR). CASE
SUMMARY: A 70-year-old man had been treated with warfarin for atrial fibrillation. He was hospitalized because of superficial thrombophlebitis of the left median cubital vein, which developed after venipuncture. An antibiotic therapy with cloxacillin was initiated immediately after the admission. Two days later, INR value increased from baseline 1.9 to 4.6. Anticoagulation therapy was discontinued and INR value was measured daily. His INR remained high for the entire duration of antibiotic therapy. Three days after the cloxacillin therapy was discontinued, the INR decreased to the baseline value. DISCUSSION: In the presented case, the temporal relationship between the administration of cloxacillin and increased INR suggests that the cloxacillin was responsible for the enhanced warfarin activity. According to the Drug Interaction Probability Scale, a causal relationship between the warfarin-cloxacillin interaction and increased INR value was rated "probable".
CONCLUSION: Interactions between warfarin and cloxacillin can result in serious adverse reactions. INR value should be closely monitored when patients are prescribed this combination of drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22677303     DOI: 10.5414/cp201700

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  2 in total

1.  A probable clinically significant interaction between warfarin and cloxacillin: three case reports.

Authors:  Hossein Khalili; Naemeh Nikvarz; Farhad Najmeddin; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2012-09-04       Impact factor: 2.953

2.  Two Strategies for the Dosage of Acenocoumarol Co-Administered with Rifampicin in Staphylococcal Prosthetic Valve Endocarditis.

Authors:  Marcin Wełnicki; Małgorzata Buksińska-Lisik; Artur Mamcarz
Journal:  Antibiotics (Basel)       Date:  2021-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.